https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536167/
Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs ...
Jul 28, 2020 ... Anti-osteoporosis medications are associated with potential increases in cardiac risk (romosozumab, calcium supplementation, menopausal hormonal ...